Q8IIG7 AF NFT

Uncharacterized protein PF3D7_1120000

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiexg3ahosxpwducqqwq7qcwoetsnbobeyqswaxvhvkevaei7zvqpm/metadata.json
IPFS of structure file: 
bafybeifhegbpumxa6bftvyzxt3zsuwk3tckbouvph5dydzokjjgik2tcm4/AF-Q8IIG7-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x80D2ac0F5e3268bC5C1d28BBAA07E3169BB02b79
First NFT owner address (bech32): 
genesis1srf2cr67xf5tchqa9za65plrz6dmq2me66p797
Current NFT ID #536476 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
536476
Accession (UniProt):
Q8IIG7
Name::
Uncharacterized protein PF3D7_1120000
Experimental Method:
Predicted structure
Sequence source:
PLASMODIUM FALCIPARUM (ISOLATE 3D7)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8IIG7 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8IIG7|YPF05_PLAF7 Uncharacterized protein PF3D7_1120000 OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=PF11_0207 PE=1 SV=2 MAKKKKQIHLNIIDFQKYYQTDDLLLDTSISTEKKTVDNQKFIRKNRTLEKDEVVQNIDWRTFDNEKEKETNNENTSNVNKIKSPGLEKKNFKKSNDVITLGARNKNKSTNLNADDIDFTNLRNKKKEDDIDFTNLRNKKKEDDLDFSNLRNKKKEEEDVDFSNLRNKKKEDDVDFSNVRNKKKEDDLDFSNVRNKKKEDDVNFSDVRNKKKEDDLDFSNVRNKKKEDDVNFSDVRNKKKEDDLDFSNVRNKKKEDDVNFSDVRNKKKEDALDFSNVRNKKKEDDLDFSNVRNKNKEDDMDFSNVRNKKKEDDLDFSNVRNKKKEDDLDFSNVRNKKKEDDLNFSNVRNKKKEDDLDFSNVRNKNKEDDMDFSNVRNKKKEDDMDFSNVRNKKKEDDLDFSNVRNKKKEDDLDFSNVRNKKKEDDLDFSNLRNKKKEESKENDTNKSEKPLYLRRLEEYRKKKKLESQANDTAMKMHEKEQIDDIQERKEEIKEEFKEEVKEEIKEIKEEIKEVKEEIKEEIKEEIKEVKEEIKEEIKEEIKEVKEEIKEVKEEIKEVKEEIKEVKEEIKEEIKEVKEEIKEEIKEEIKEVKEEIKEEVKEEIKEVKEEIKEVKEEIKEEVKEEIKEVKEEIKEVKEEIKEEIKEVKEEIKEEVKEEIKEEIKEIKEELKNDISSETTKEEKNTEHKKEETEKKKFIPKRVIMYQQELKEKEERNLKLLEQQRKEREMRLQLIRSKTQGTSSTFIPSAKLKHLESLKEEKKKEVKTNIQPKDNNNNNNNNNNNNNNIAVLKNNKNEEQNVIKKKSIFLEIAEKTENAKIVEKTDIEEIAKKKREELYKKQLEKITKKNEEHLKYNNIYKHDVNIIKNFYNEIKDKIIQNYYFNQDDCISLCSILKTDDCNYMESHVPFYVVISIFMLSLPQKLQNDDYFKRASNIKNLLIYLKENSKIENHEDYILNDTLKFCDQLKYPHLSEETSLIETIFDTLLYSGVISKNSFIQWFQDDDSNAELKSKAMLQLIYWHKWLTEEEKDQEEEIDELDDTEEKNISDVSDIEKNVPKNFIFKKIKKKLF